NYSE:HIMS

Hims & Hers Health Competitors

$11.48
+0.03 (+0.26 %)
(As of 05/5/2021 12:00 AM ET)
Add
Compare
Today's Range
$11.35
$11.92
50-Day Range
$9.89
$16.38
52-Week Range
$9.86
$25.40
Volume525,839 shs
Average Volume1.98 million shs
Market Capitalization$2.20 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Hims & Hers Health (NYSE:HIMS) Vs. COUR, APPH, YQ, FHS, MITC, and WTER

Should you be buying HIMS stock or one of its competitors? Companies in the sector of "consumer defensive" are considered alternatives and competitors to Hims & Hers Health, including Coursera (COUR), AppHarvest (APPH), 17 Education & Technology Group (YQ), First High-School Education Group (FHS), Meat-Tech 3D (MITC), and The Alkaline Water (WTER).

Hims & Hers Health (NYSE:HIMS) and Coursera (NASDAQ:COUR) are both mid-cap consumer defensive companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, analyst recommendations, dividends, earnings, profitability, valuation and institutional ownership.

Valuation and Earnings

This table compares Hims & Hers Health and Coursera's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hims & Hers HealthN/AN/AN/AN/AN/A
CourseraN/AN/AN/AN/AN/A

Profitability

This table compares Hims & Hers Health and Coursera's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Hims & Hers HealthN/AN/AN/A
CourseraN/AN/AN/A

Analyst Recommendations

This is a breakdown of current recommendations and price targets for Hims & Hers Health and Coursera, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Hims & Hers Health05202.29
Coursera021502.88

Hims & Hers Health currently has a consensus price target of $16.20, suggesting a potential upside of 41.11%. Coursera has a consensus price target of $51.6667, suggesting a potential upside of 22.99%. Given Hims & Hers Health's higher possible upside, research analysts clearly believe Hims & Hers Health is more favorable than Coursera.

Summary

Coursera beats Hims & Hers Health on 2 of the 3 factors compared between the two stocks.

AppHarvest (NASDAQ:APPH) and Hims & Hers Health (NYSE:HIMS) are both consumer defensive companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, risk, dividends, institutional ownership, earnings, profitability and valuation.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for AppHarvest and Hims & Hers Health, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
AppHarvest00103.00
Hims & Hers Health05202.29

AppHarvest presently has a consensus target price of $42.00, suggesting a potential upside of 190.26%. Hims & Hers Health has a consensus target price of $16.20, suggesting a potential upside of 41.11%. Given AppHarvest's stronger consensus rating and higher probable upside, equities analysts clearly believe AppHarvest is more favorable than Hims & Hers Health.

Profitability

This table compares AppHarvest and Hims & Hers Health's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
AppHarvestN/AN/AN/A
Hims & Hers HealthN/AN/AN/A

Valuation and Earnings

This table compares AppHarvest and Hims & Hers Health's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AppHarvestN/AN/AN/AN/AN/A
Hims & Hers HealthN/AN/AN/AN/AN/A

Summary

AppHarvest beats Hims & Hers Health on 2 of the 3 factors compared between the two stocks.

Hims & Hers Health (NYSE:HIMS) and 17 Education & Technology Group (NYSE:YQ) are both consumer defensive companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, dividends, valuation, institutional ownership, profitability and risk.

Valuation and Earnings

This table compares Hims & Hers Health and 17 Education & Technology Group's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hims & Hers HealthN/AN/AN/AN/AN/A
17 Education & Technology GroupN/AN/AN/AN/AN/A

Profitability

This table compares Hims & Hers Health and 17 Education & Technology Group's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Hims & Hers HealthN/AN/AN/A
17 Education & Technology GroupN/AN/AN/A

Analyst Ratings

This is a summary of current ratings for Hims & Hers Health and 17 Education & Technology Group, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Hims & Hers Health05202.29
17 Education & Technology Group00203.00

Hims & Hers Health currently has a consensus price target of $16.20, indicating a potential upside of 41.11%. 17 Education & Technology Group has a consensus price target of $21.00, indicating a potential upside of 250.58%. Given 17 Education & Technology Group's stronger consensus rating and higher probable upside, analysts plainly believe 17 Education & Technology Group is more favorable than Hims & Hers Health.

Summary

17 Education & Technology Group beats Hims & Hers Health on 2 of the 2 factors compared between the two stocks.

Hims & Hers Health (NYSE:HIMS) and First High-School Education Group (NYSE:FHS) are both consumer defensive companies, but which is the better business? We will compare the two companies based on the strength of their dividends, valuation, earnings, analyst recommendations, profitability, institutional ownership and risk.

Profitability

This table compares Hims & Hers Health and First High-School Education Group's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Hims & Hers HealthN/AN/AN/A
First High-School Education GroupN/AN/AN/A

Valuation & Earnings

This table compares Hims & Hers Health and First High-School Education Group's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hims & Hers HealthN/AN/AN/AN/AN/A
First High-School Education GroupN/AN/AN/AN/AN/A

Analyst Recommendations

This is a breakdown of current recommendations and price targets for Hims & Hers Health and First High-School Education Group, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Hims & Hers Health05202.29
First High-School Education Group00103.00

Hims & Hers Health presently has a consensus price target of $16.20, suggesting a potential upside of 41.11%. Given Hims & Hers Health's higher possible upside, analysts plainly believe Hims & Hers Health is more favorable than First High-School Education Group.

Summary

Hims & Hers Health beats First High-School Education Group on 2 of the 3 factors compared between the two stocks.

Meat-Tech 3D (NASDAQ:MITC) and Hims & Hers Health (NYSE:HIMS) are both consumer defensive companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, profitability, valuation, earnings, risk and institutional ownership.

Earnings and Valuation

This table compares Meat-Tech 3D and Hims & Hers Health's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Meat-Tech 3DN/AN/AN/AN/AN/A
Hims & Hers HealthN/AN/AN/AN/AN/A

Analyst Ratings

This is a summary of recent recommendations and price targets for Meat-Tech 3D and Hims & Hers Health, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Meat-Tech 3D0000N/A
Hims & Hers Health05202.29

Hims & Hers Health has a consensus target price of $16.20, suggesting a potential upside of 41.11%. Given Hims & Hers Health's higher probable upside, analysts plainly believe Hims & Hers Health is more favorable than Meat-Tech 3D.

Profitability

This table compares Meat-Tech 3D and Hims & Hers Health's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Meat-Tech 3DN/AN/AN/A
Hims & Hers HealthN/AN/AN/A

Summary

Hims & Hers Health beats Meat-Tech 3D on 2 of the 2 factors compared between the two stocks.

The Alkaline Water (NYSE:WTER) and Hims & Hers Health (NYSE:HIMS) are both consumer defensive companies, but which is the better investment? We will compare the two companies based on the strength of their risk, valuation, dividends, analyst recommendations, earnings, profitability and institutional ownership.

Valuation and Earnings

This table compares The Alkaline Water and Hims & Hers Health's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
The Alkaline WaterN/AN/AN/AN/AN/A
Hims & Hers HealthN/AN/AN/AN/AN/A

Analyst Ratings

This is a summary of current recommendations for The Alkaline Water and Hims & Hers Health, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
The Alkaline Water00203.00
Hims & Hers Health05202.29

Hims & Hers Health has a consensus target price of $16.20, suggesting a potential upside of 41.11%. Given Hims & Hers Health's higher possible upside, analysts clearly believe Hims & Hers Health is more favorable than The Alkaline Water.

Profitability

This table compares The Alkaline Water and Hims & Hers Health's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
The Alkaline WaterN/AN/AN/A
Hims & Hers HealthN/AN/AN/A


Hims & Hers Health Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
COUR
Coursera
1.9$42.01+8.7%$5.47 billionN/A0.00Analyst Report
Quiet Period Expiration
Gap Down
APPH
AppHarvest
1.2$14.47+7.9%$1.42 billionN/A0.00
YQ
17 Education & Technology Group
1.2$5.99+2.8%$1.15 billionN/A0.00
FHS
First High-School Education Group
0.0$6.76+0.3%$195.68 millionN/A0.00Analyst Report
MITC
Meat-Tech 3D
0.0$7.77+0.4%$95.61 millionN/A0.00News Coverage
The Alkaline Water logo
WTER
The Alkaline Water
0.5$1.06+0.9%$92.48 millionN/A0.00
PLAG
Planet Green
0.0$1.92+0.5%$38.42 millionN/A0.00Gap Up
DOGZ
Dogness (International)
0.5$1.57+1.3%$31.87 millionN/A0.00Decrease in Short Interest
CHS logo
CHSCL
CHS
0.5$28.68+0.2%$0.00N/A0.00
CHS logo
CHSCM
CHS
0.7$27.64+0.0%$0.00N/A0.00
CHS logo
CHSCO
CHS
0.5$28.49+0.2%$0.00N/A0.00Decrease in Short Interest
Demand Brands logo
DMAN
Demand Brands
0.4$0.01+6.7%$0.00N/A0.00Gap Down
Good Hemp logo
GHMP
Good Hemp
0.0$1.11+8.1%$0.00N/A0.00Gap Up
TAP.A
Molson Coors Brewing
0.4$58.00+3.4%$0.00N/A0.00Earnings Announcement
Gap Up
QNTA
Quanta
0.0$0.09+10.6%$0.00N/A0.00High Trading Volume
Gap Down
SHRG
Sharing Services Global
0.0$0.20+10.0%$0.00N/A0.00Gap Down
This page was last updated on 5/6/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.